Symptomatic Intracerebral Hemorrhage following Thrombolytic Therapy for Acute Ischemic Stroke: A Review of the Risk Factors

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cerebrovascular Diseases

• Publication date

  2007-05-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000103110PMID 17519538
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reply to the Letter by Lodder: Size Criterion for Lacunar Infarction

  2007cited by this paper
• Mobilisation ‘in Bed’ Is Not Mobilisation

  2007cited by this paper
• Reversible Posterior Leukoencephalopathy Syndrome in Catastrophic Antiphospholipid Syndrome

  2007cited by this paper
• Contrast-Induced Neurotoxicity and Selective Cortical Injury

  2007cited by this paper
• Emergency Surgical Revascularization in a Patient with Acute Symptomatic Common Carotid Artery Occlusion

  2007cited by this paper
• Asymptomatic Recurrent Cerebral Ischaemic Lesions on Diffusion-Weighted Imaging in the Subacute and Chronic Phase after Transient Ischaemic Attack or Minor Ischaemic Stroke

  2007cited by this paper
• Extent of Early Ischemic Changes on Computed Tomography (CT) Before Thrombolysis: Prognostic Value of the Alberta Stroke Program Early CT Score in ECASS II

  2006cited by this paper
• Pretreatment Hemostatic Markers of Symptomatic Intracerebral Hemorrhage in Patients Treated With Tissue Plasminogen Activator

  2006cited by this paper
• Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke.

  2006cited by this paper
• Intravenous thrombolysis in stroke patients of > or = 80 versus < 80 years of age--a systematic review across cohort studies.

  2006cited by this paper
• Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study

  2006cited by this paper
• Evaluating therapeutic targets for reperfusion‐related brain hemorrhage

  2006cited by this paper
• Markedly Reduced Apparent Blood Volume on Bolus Contrast Magnetic Resonance Imaging as a Predictor of Hemorrhage After Thrombolytic Therapy for Acute Ischemic Stroke

  2005cited by this paper
• Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association.

  2005cited by this paper
• Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study

  2005cited by this paper
• Prediction of hemorrhagic transformation in acute ischemic stroke: role of diffusion-weighted imaging and early parenchymal enhancement.

  2005cited by this paper
• The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase

  2005cited by this paper
• Intravenous TPA for Very Old Stroke Patients

  2005cited by this paper
• Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis

  2005cited by this paper
• Clinical importance of microbleeds in patients receiving IV thrombolysis

  2005cited by this paper
• Admission Fibrinolytic Profile Is Associated With Symptomatic Hemorrhagic Transformation in Stroke Patients Treated With Tissue Plasminogen Activator

  2004cited by this paper
• Mechanisms of Hemorrhagic Transformation After Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke

  2004cited by this paper
• Plasma Cellular-Fibronectin Concentration Predicts Hemorrhagic Transformation After Thrombolytic Therapy in Acute Ischemic Stroke

  2004cited by this paper
• Evidence of Reperfusion Injury, Exacerbated by Thrombolytic Therapy, in Human Focal Brain Ischemia Using a Novel Imaging Marker of Early Blood–Brain Barrier Disruption

  2004cited by this paper
• Predictors of Hyperacute Clinical Worsening in Ischemic Stroke Patients Receiving Thrombolytic Therapy

  2004cited by this paper
• Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Effect of hyperglycemia on stroke outcomes.

  2004cited by this paper
• Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

  2004cited by this paper
• Admission fibrinolytic profile predicts clot lysis resistance in stroke patients treated with tissue plasminogen activator

  2004cited by this paper
• The structural basis for the pathophysiological relevance of PAI-1 in cardiovascular diseases and the development of potential PAI-1 inhibitors

  2004cited by this paper
• Thrombolysis for Ischemic Stroke in Patients with Old Microbleeds on Pretreatment MRI

  2003cited by this paper
• Matrix Metalloproteinase-9 Pretreatment Level Predicts Intracranial Hemorrhagic Complications After Thrombolysis in Human Stroke

  2003cited by this paper
• MR imaging enhancement patterns as predictors of hemorrhagic transformation in acute ischemic stroke.

  2003cited by this paper
• Acetylsalicylic Acid Pretreatment, Concomitant Heparin Therapy and the Risk of Early Intracranial Hemorrhage following Systemic Thrombolysis for Acute Ischemic Stroke

  2003cited by this paper
• Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator–Treated Patients

  2003cited by this paper
• Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association

  2003cited by this paper
• Tissue Plasminogen Activator for Acute Ischemic Stroke in Clinical Practice: A Meta-Analysis of Safety Data

  2003cited by this paper
• Baseline Blood Pressure but Not Early Computed Tomography Changes Predicts Major Hemorrhage After Streptokinase in Acute Ischemic Stroke

  2002cited by this paper
• Markers of Increased Risk of Intracerebral Hemorrhage After Intravenous Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke in Clinical Practice: The Multicenter rt-PA Acute Stroke Survey

  2002cited by this paper
• Brain hemorrhage after thrombolysis: good or bad?

  2002cited by this paper
• Predictors of Hemorrhagic Transformation After Intravenous Recombinant Tissue Plasminogen Activator: Prognostic Value of the Initial Apparent Diffusion Coefficient and Diffusion-Weighted Lesion Volume

  2002cited by this paper
• Brain Hemorrhage After Thrombolysis: Good or Bad?

  2002cited by this paper
• Predictors of Hemorrhagic Transformation in Patients Receiving Intra-Arterial Thrombolysis

  2002cited by this paper
• Prediction of Hemorrhagic Transformation After Thrombolytic Therapy of Clot Embolism: An MRI Investigation in Rat Brain

  2002cited by this paper
• Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial

  2002cited by this paper
• Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke

  2001cited by this paper
• Delayed rt-PA Treatment in a Rat Embolic Stroke Model: Diagnosis and Prognosis of Ischemic Injury and Hemorrhagic Transformation with Magnetic Resonance Imaging

  2001cited by this paper
• Lack of clinical significance of early ischemic changes on computed tomography in acute stroke.

  2001cited by this paper
• Antithrombotic and thrombolytic therapy for ischemic stroke.

  2001cited by this paper
• Early Computed Tomography Hypodensity Predicts Hemorrhage After Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke

  2001cited by this paper
• Risk Factors for Severe Hemorrhagic Transformation in Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator: A Secondary Analysis of the European-Australasian Acute Stroke Study (ECASS II)

  2001cited by this paper
• The validity and reliability of signs of early infarction on CT in acute ischaemic stroke

  2000cited by this paper
• Metalloproteinase Inhibition Reduces Thrombolytic (Tissue Plasminogen Activator)–Induced Hemorrhage After Thromboembolic Stroke

  2000cited by this paper
• Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score.

  2000cited by this paper
• Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

  1999cited by this paper
• Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group.

  1999cited by this paper
• Evaluation of early computed tomographic findings in acute ischemic stroke.

  1999cited by this paper
• Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy.

  1999cited by this paper
• Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke.

  1999cited by this paper
• Can stroke physicians and neuroradiologists identify signs of early cerebral infarction on CT?

  1999cited by this paper
• Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial

  1999cited by this paper
• Cranial computed tomography interpretation in acute stroke: physician accuracy in determining eligibility for thrombolytic therapy.

  1998cited by this paper
• Antithrombotic and thrombolytic therapy for ischemic stroke.

  1998cited by this paper
• Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke

  1998cited by this paper
• Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

  1998cited by this paper
• Hyperglycemia and the vascular effects of cerebral ischemia.

  1997cited by this paper
• Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial.

  1997cited by this paper
• Acute stroke: usefulness of early CT findings before thrombolytic therapy.

  1997cited by this paper
• Hyperglycemia and the vascular effects of cerebral ischemia.

  1997cited by this paper
• Interobserver agreement in assessing early CT signs of middle cerebral artery infarction.

  1996cited by this paper
• Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

  1995cited by this paper
• Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper
• RANDOMIZED CONTROLLED TRIAL OF STREPTOKINASE, ASPIRIN, AND COMBINATION OF BOTH IN TREATMENT OF ACUTE ISCHEMIC STROKE

  1995cited by this paper
• Hyperglycemia and hemorrhagic transformation of cerebral infarcts.

  1995cited by this paper
• Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

  1995cited by this paper
• Moderate Hyperglycemia Worsens Acute Blood‐Brain Barrier Injury After Forebrain Ischemia in Rats

  1993cited by this paper
• Thrombolytic agents in the treatment of stroke.

  1990cited by this paper
• Metalloproteinases and their inhibitors in matrix remodeling.

  1990cited by this paper

• Low Fibrinogen Levels Are Associated with an Increased Risk of Parenchymal Hematoma in Ischemic Stroke Treated with Intravenous Thrombolysis

  2026cites this paper
• Prognostic value of lymphocyte counts in patients with acute ischemic stroke receiving intravenous thrombolysis

  2025cites this paper
• Analysis of hemorrhagic transformation and intracerebral hemorrhage under combination therapy with alteplase and antiplatelets or anticoagulants, using the Japanese Adverse Drug Event Report database

  2025cites this paper
• Influence of impaired renal function on the outcomes of patients with acute ischaemic stroke treated with intravenous tenecteplase and alteplase: a post hoc analysis of the TRACE-2 trial

  2025cites this paper
• Just the facts: management of thrombolytic complications in acute stroke care in the emergency department.

  2024cites this paper
• Intravenous thrombolysis in acute ischemic stroke patients with pre‐stroke disability: A systematic review and meta‐analysis

  2024cites this paper
• Lipid engineered nanomaterials: A novel paradigm shift for combating stroke

  2024cites this paper
• Hemorrhage induced by antithrombotic agents: new insights from a real-world pharmacovigilance study

  2024cites this paper
• Blood glucose level affects prognosis of patients who received intravenous thrombolysis after acute ischemic stroke? A meta-analysis

  2023cites this paper
• Reversing memory/cognitive impairment with medicinal plants targeting inflammation and its crosstalk with other pathologies

  2023cites this paper
• Association between infarct location and haemorrhagic transformation of acute ischaemic stroke after intravenous thrombolysis.

  2023cites this paper
• Exosome-Coated tPA/Catalase Nanoformulation for Thrombolytic Therapy

  2023cites this paper
• Mechanical thrombectomy in stroke patients of working age: Real-world outcomes in Sweden

  2022cites this paper
• Association between malnutrition risk and hemorrhagic transformation in patients with acute ischemic stroke

  2022cites this paper
• Thrombolytic tPA-induced hemorrhagic transformation of ischemic stroke is mediated by PKCβ phosphorylation of occludin

  2022cites this paper
• Diabetes and the treatment of ischemic stroke.

  2022cites this paper
• Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review

  2022cites this paper
• Comparison of magnetic resonance imaging versus computed tomography‐based thrombolysis treatment in patients with acute ischemic stroke

  2022cites this paper
• Post-Thrombolytic D-Dimer Elevation Predicts Symptomatic Intracranial Hemorrhage and Poor Functional Outcome After Intravenous Thrombolysis in Acute Ischemic Stroke Patients

  2022cites this paper
• Post-Thrombolytic D-Dimer Elevation Predicts Symptomatic Intracranial Hemorrhage and Poor Functional Outcome After Intravenous Thrombolysis in Acute Ischemic Stroke Patients

  2022cites this paper
• Ambiguities in blood pressure management in acute ischaemic stroke.

  2021cites this paper
• A risk score for prediction of symptomatic intracerebral haemorrhage following thrombolysis

  2021cites this paper
• Causality assessment between reported fatal cerebral haemorrhage and suspected drugs: developing a new algorithm based on the analysis of the Japanese Adverse Event Report (JADER) database and literature review

  2021cites this paper
• The Osteoporotic Condition as a Predictive Factor for Hemorrhagic Transformation in Acute Cardioembolic Stroke

  2021cites this paper
• Quality of Care and One-Year Outcomes in Patients with Diabetes Hospitalised for Stroke or TIA: A Linked Registry Study.

  2021cites this paper
• Factors Contributing to an Efficacious Endovascular Treatment for Acute Ischemic Stroke in Asian Population

  2021cites this paper
• Plasma C-Reactive Protein Level and Outcome of Acute Ischemic Stroke Patients Treated by Intravenous Thrombolysis: A Systematic Review and Meta-Analysis

  2021cites this paper
• Hemodynamics in acute stroke: Cerebral and cardiac complications.

  2021cites this paper
• Effect of cerebral microbleeds on hemorrhagic transformation and functional prognosis after intravenous thrombolysis of cerebral infarction

  2021cites this paper
• Practice variation in the informed consent procedure for thrombolysis in acute ischemic stroke: a survey among neurologists and neurology residents

  2021influential citation
• Clinical and Non-Clinical Determinants of the Effect of Mechanical Thrombectomy and Post-Stroke Functional Status of Patients in Short and Long-Term Follow-Up

  2021cites this paper
• Heparin and Arginine Based Plasmin Nanoformulation for Ischemic Stroke Therapy

  2021cites this paper
• Hemorrhagic stroke.

  2021cites this paper
• Intravenous thrombolysis in patients with chronic kidney disease

  2020cites this paper
• Predictors for the extent of pial collateral recruitment in acute ischemic stroke

  2020cites this paper
• Intracranial Hemorrhage After Reperfusion Therapies in Acute Ischemic Stroke Patients

  2020cites this paper
• Efeitos motores de um programa de exercício aeróbio na função do membro superior parético em pacientes hemiparéticos crônicos pós acidente vascular encefálico

  2020cites this paper
• Effect of off-hour versus work-hour thrombolysis for acute ischemic stroke on emergency department patients' outcome: a retrospective study.

  2020cites this paper
• Safety and efficacy of dual antiplatelet pretreatment in patients with ischemic stroke treated with IV thrombolysis

  2020cites this paper
• Smart diagnostic nano-agents for cerebral ischemia.

  2020cites this paper
• Permeability Measures Predict Hemorrhagic Transformation after Ischemic Stroke

  2020cites this paper
• Applications of Quantitative Perfusion and Permeability in the Brain

  2020cites this paper
• Liver Fibrosis Is Associated With Hemorrhagic Transformation in Patients With Acute Ischemic Stroke

  2020cites this paper
• Stomatin-like protein-2 confers neuroprotection effect in oxygen-glucose deprivation/reoxygenation-injured neurons by regulating AMPK/Nrf2 signalling

  2019cites this paper
• Pedalling-based exercise performance and prevention of post-thrombolysis intracerebral haemorrhage in stroke patients

  2019influential citation
• Low triiodothyronine syndrome is associated with hemorrhagic transformation in patients with acute ischaemic stroke

  2019cites this paper
• Intravenous Thrombolysis

  2019cites this paper
• Hematologic Interventions for Acute Central Nervous System Disease

  2019cites this paper
• Mechanical thrombectomy outcomes in large vessel stroke with high international normalized ratio.

  2019cites this paper
• Efficacy and Safety of Intravenous Thrombolysis in Patients with Unknown Onset Stroke: A Meta-Analysis

  2019cites this paper
• Early Fibrinogen Depletion and Symptomatic Intracranial Hemorrhage After Reperfusion Therapy.

  2019cites this paper
• tPA mediated activation of PDGF-C/PDGFRα signaling in the CNS

  2019cites this paper
• Statin, cholesterol, and sICH after acute ischemic stroke: systematic review and meta-analysis

  2019cites this paper
• Intracerebral hemorrhage after thrombolysis with recombinant tissue plasminogen activator in a patient treated with edoxaban

  2019cites this paper
• Cathepsin K Knockout Exacerbates Haemorrhagic Transformation Induced by Recombinant Tissue Plasminogen Activator After Focal Cerebral Ischaemia in Mice

  2019cites this paper
• Management of Blood Pressure During and After Recanalization Therapy for Acute Ischemic Stroke

  2019cites this paper
• A hemorrhagic transformation model of mechanical stroke therapy with acute hyperglycemia in mice

  2018cites this paper
• Outcome of Acute Ischemic Stroke after the Treatment with Edaravone and 0.6 Mg/Kg Alteplase in Japanese Patients with Diabetes.

  2018cites this paper
• Relevance of standard intravenous thrombolysis in endovascular stroke therapy of a tertiary stroke center

  2018cites this paper
• Electroacupunture contributes to recovery of neurological deficits in experimental stroke by activating astrocytes

  2018cites this paper
• Management of Stroke in the Neurocritical Care Unit

  2018cites this paper
• Przegląd czynników ryzyka krwotoku wewnątrzczaszkowego po dożylnym leczeniu trombolitycznym udaru niedokrwiennego mózgu

  2018cites this paper
• Impact of varying levels of hyperglycemia on clinicoradiographic outcomes after endovascular reperfusion treatment

  2018cites this paper
• Increased Risk of Intracranial Hemorrhage and Mortality Following Thrombolysis in Patients with Stroke and Active Cancer

  2018cites this paper
• Hémorragie intracrânienne et pronostic fonctionnel post-AVC chez les patients traités par thrombolyse et thrombectomie : influence des antiagrégants plaquettaires

  2018cites this paper
• Update in the Early Management and Reperfusion Strategies of Patients with Acute Ischemic Stroke

  2018cites this paper
• Prognostic factors in patients with acute ischemic stroke treated with intravenous tissue plasminogen activator: The first study among Iranian patients

  2018cites this paper
• Evaluating the Impact of Personalized Stroke Management Tool Kits on Patient Experience and Stroke Recovery

  2018cites this paper
• Early changes in fibrinogen after administration of alteplase are associated with the short-term efficacy of thrombolysis

  2018cites this paper
• Predictors of Symptomatic Intracranial Hemorrhage after Endovascular Therapy in Acute Ischemic Stroke with Large Vessel Occlusion.

  2017cites this paper
• Prediction of hemorrhagic transformation after acute thrombolysis following major artery occlusion using relative ADC ratio: A retrospective study.

  2017cites this paper
• Thrombolyse intraveineuse dans les infarctus cérébraux aigus dans un centre sans unité neurovasculaire : expérience du centre hospitalier de Cayenne

  2017cites this paper
• Thrombosis, Neuroinflammation, and Poststroke Infection: The Multifaceted Role of Neutrophils in Stroke

  2017cites this paper
• Regulatory T cells ameliorate tissue plasminogen activator-induced brain haemorrhage after stroke

  2017cites this paper
• Predictors of functional outcome and hemorrhagic complications in acute ischemic stroke patients treated with intravenous thrombolysis - A retrospective analysis
.

  2017cites this paper
• The risk of intravenous thrombolysis-induced intracranial hemorrhage in Taiwanese patients with unruptured intracranial aneurysm

  2017cites this paper
• Thrombolysis and thrombectomy for acute ischaemic stroke

  2017cites this paper
• Cerebral Amyloid Angiopathy in Stroke Medicine.

  2017cites this paper
• Diabetes, adult neurogenesis and brain remodeling: New insights from rodent and zebrafish models

  2017cites this paper
• Blood pressure control for acute severe ischemic and hemorrhagic stroke

  2017cites this paper
• High-permeability region size on perfusion CT predicts hemorrhagic transformation after intravenous thrombolysis in stroke

  2017cites this paper
• Association of fibrinogen level with early neurological deterioration among acute ischemic stroke patients with diabetes

  2017cites this paper
• MR imaging in hyperacute ischemic stroke.

  2017cites this paper
• Glucagon‐like receptor 1 agonists and DPP‐4 inhibitors: Anti‐diabetic drugs with anti‐stroke potential

  2017cites this paper
• Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke

  2017cites this paper
• Three Stages of Evolution in the Treatment of Acute Ischemic Stroke: Stroke Unit Care, Intravenous Thrombolysis and Endovascular Therapy

  2017cites this paper
• 47 – Computed Tomography-based Evaluation of Cerebrovascular Disease

  2016cites this paper
• tPA Modulation of the Blood–Brain Barrier: A Unifying Explanation for the Pleiotropic Effects of tPA in the CNS

  2016cites this paper
• Blood Pressure in Acute Ischemic Stroke

  2016cites this paper
• The Oxfordshire Community Stroke Project classification system predicts clinical outcomes following intravenous thrombolysis: a prospective cohort study

  2016influential citation
• The role of connexin43 in hemorrhagic transformation after thrombolysis in vivo and in vitro.

  2016influential citation
• Glucocorticoid treatment inhibits intracerebral hemorrhage‑induced inflammation by targeting the microRNA‑155/SOCS‑1 signaling pathway.

  2016cites this paper
• Asia Pacific Stroke Conference 2016. Abstracts of the Annual Conference of theAsia Pacific Stroke Organization (APSO) Combined with Stroke Society of Australasia, Brisbane, Qld., Australia, July 14-17, 2016: Abstracts

  2016cites this paper
• Ischemic stroke outcome: A review of the influence of post-stroke complications within the different scenarios of stroke care.

  2016cites this paper
• Risk communication in the hyper-acute setting of stroke thrombolysis: an interview study of clinicians

  2016cites this paper
• Association of Acute and Chronic Hyperglycemia With Acute Ischemic Stroke Outcomes Post‐Thrombolysis: Findings From Get With The Guidelines‐Stroke

  2015cites this paper
• Permeability Parameters Measured with Dynamic Contrast-Enhanced MRI: Correlation with the Extravasation of Evans Blue in a Rat Model of Transient Cerebral Ischemia

  2015cites this paper
• Cortical Superficial Siderosis and Risk of Bleeding after Thrombolysis for Ischemic Stroke

  2015cites this paper
• Perfusion CT for selecting patients with acute ischemic stroke for intravenous thrombolytic therapy.

  2015cites this paper
• PPAR-Alpha Agonist Used at the Acute Phase of Experimental Ischemic Stroke Reduces Occurrence of Thrombolysis-Induced Hemorrhage in Rats

  2015cites this paper